title: LNCaP Res

status: Public on Jan 07 2022

city: St Louis

first: Tiandao

last: Li

state: MO

address: 4444 Forest Park Ave

institute: Washington University

description: LnCaP Enzal resistant

data_processing:
Raw fastq files were aligned against human genome hg38 assembly using Burrows-Wheeler Alignment tool and then processed using methylQA to generate bed and bigwig files.
The MACS2 peak caller was used to compare the ChIP-Seq signal to a corresponding input control to identify narrow regions of enrichment (peaks) using default parameters.
ChIP-Seq signals and peak locations were further visualized using UCSC Genome Browser.
The top 500-1000 ChIP-Seq peaks were assigned to the nearest genes using the annotatePeaks function from HOMER2, motif binding sites were determined using HOMer2, and GO and pathway enrichment analyses were performed by EnrichR.
Genome_build: hg38
Supplementary_files_format_and_content: fastq and peak files

source_name: Prostate Cancer

growth_protocol: VCaP cells were grown in DMEM media with charcoal stripped fetal bovine serum. LNCaP cells were vehicle (DMSO) treated, or Enzalutamide treated or Enzalutamide and ( R)-9b treated

extract_protocol:
The lysates were immunoprecipitation with acK609-AR antibodies (2 ug) for overnight.
Ten nanograms of immunoprecipitated DNA was fragmented to 300 base pairs using a Covaris M220 Focused-ultrasonicator (Covaris, Inc., Woburn, MA) and then used to generate sequencing libraries using the Kapa Hyper Prep Kit (Roche Sequencing Solutions Inc., Pleasanton, CA). The size and quality of the library was evaluated using the Agilent BioAnalyzer (Agilent Technologies, Inc., Santa Clara, CA), and the library was quantitated with the Kapa Library Quantification Kit.  Each enriched DNA library was then sequenced on an Illumina NextSeq 500 sequencer to generate 40-50 million 75-base paired-end reads (Illumina, Inc., San Diego, CA).  The raw sequence data were aligned using BowTie 2 [1], and the binding sites were identified using the MACS peak-finding software

treatment_protocol: 5x10^7 VCaP cells were treated with R-9b inhibitor overnight (5 uM) and lysates were prepared by sonication in RLB bufffer. 5x10^7 LNCaP cells were treated with Enzalutamide for 72 hours, or Enzalutamide for 72 hours & R-9b inhibitor overnight (5 uM) and lysates were prepared by sonication in RLB bufffer

value: Enzalutamide treated

value: Prostate Cancer Cell Line

tag: chip antibody

value: acK609-AR antibody


title: LNCaP Res+R(9b)

type: SRA

country: USA

description: LnCaP Enzal sensitive

library_source: genomic

molecule: genomic DNA

organism: Homo sapiens

tag: treatment

value: Enzalutamide & R-9b treated

tag: cell type


title: LNCaP Veh

description: LnCaP Untreated

value: Vehicle(DMSO) treated


title: AID-TRRAP-cloneAT63-IAA-12h-HA-CR21

city: Montpellier

first: Dominique

last: Helmlinger

address: 1919 route de Mende

department: CRBM

country: France

institute: CNRS

data_processing:
Library strategy: CUT&RUN
Basecalling pipeline at Fasteris: HiSeq Control Software HD 3.4.0.38; RTA 2.7.7; bcl2fastq2.17 v2.17.1.14
Sequenced reads were trimmed for Illumina adaptor sequence using Trimmommatic tool v0.36.5 and mapped to human genome assembly GRCh37 (hg19) using Bowtie2 v2.3.4.2 with paired-end option fragment length for valid paired-end alignment set from 10 to 700, and otherwise default options.
Peak calling was performed using MACS2 callpeak tool v2.1.1.20160309.0, options --format BAMPE, --bw 300, --mfold and --qvalue set to default values and --bdg. In both analysis (either NaOH or IAA treatment), replicates were analyzed against the IgG control sample.
Genome_build: GRCh37 (hg19)
Supplementary_files_format_and_content: NarrowPeaks outputfile in BED 6+4 format were pooled into one Excel spreadsheet. Tabs report the MACS2 analysis of TRRAP peak calling in cells treated with NaOH (presence of TRRAP) and with IAA (TRRAP depletion).

source_name: Adherent cells

growth_protocol: Non-confluent HCT116 cells grown in MCCOYS’5A medium (Sigma) supplemented with 10% (v/v) FBS and 100 U/ml Penicillin/Streptomycin in 5% CO2 at 37°C

extract_protocol:
CUT&RUN experiments were implemented based on the procedure described by Meers et al, 2019 (doi: 10.7554/eLife.46314). Briefly, 250,000 cells were immobilized on 10ul of concavalin A-coated beads, permeabilized with digitonin, and incubated overnight at 4°C with an anti-HA tag antibody. The pA-MNase recombinant fusion protein was incubated at 4°C for 1h, at a final concentration of 700 ng/mL and then activated with CaCl2 during 30 min at 0°C. The reaction is stopped and DAN fragments are resealed by incubation at 37°C for 15min. Library were then constructed from released DNA fragments purified on NucleoSpin columns (Macherey-Nagel).
Libraries for Illumina sequencing were prepared with KAPA Single-Indexed adapters set A&B and the Hyper Prep kit (KAPA Biosystems).

treatment_protocol: NaOH at 0.01% or 3-Indoleacetic acid (IAA) (Sigma, I2886) at 0.5 mM for 12 hours

tag: genotype

value: TIR1 AID-TRRAP

value: IAA


title: AID-TRRAP-cloneAT63-IAA-12h-HA-CR20


title: AID-TRRAP-cloneAT63-NaOH-12h-HA-CR21

value: NaOH


title: AID-TRRAP-cloneAT63-NaOH-Control-IgG-CR21


title: AID-TRRAP-cloneAT63-NaOH-12h-HA-CR20


title: WT-3 RNAseq

status: Public on Jan 08 2022

city: Ann Arbor

first: Jiandie

last: Lin

state: MI

address: 210 Washtenaw Ave

department: Cell & Developmental Biology, Life Science Institute

institute: University of Michigan

description: Mouse quadriceps was harvested and immediately frozen into liquid nitrogen. RNA was extract by TRIzol.  Sequencing library was constructed from more than 400ng of total RNA by BGI sequencing service.

library_source: transcriptomic

data_processing:
FastQC was used to assess the sequencing quality on fastq files.
STAR was used for alignment to generate bam files.
The reads aligned to each gene feature were counted by htseq.
R package DESeq2 was used for differential expression analysis.
Genome_build: mm10
Supplementary_files_format_and_content: Processed data files contain DESeq2-normalized read counts from bulk RNA-seq

molecule: total RNA

organism: Mus musculus

source_name: quadriceps

tag: strain

tag: tissue

value: quadriceps

tag: phenotype

value: WT


title: WT-1 RNAseq

extract_protocol: Mouse quadriceps was harvested and immediately frozen into liquid nitrogen. RNA was extract by TRIzol.  Sequencing library was constructed from more than 400ng of total RNA by BGI sequencing service.


title: WholeBlood_CRC305D2GENT010602_Day7

type: RNA

city: London

first: David

last: Lewis

address: Du Cane Road

department: ICRF

country: United Kingdom

institute: Imperial College London

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT010602 on day 7

hyb_protocol: 600 ng of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was fragmented and hybridized to custom whole genome human 8 × 60K multipack microarrays (Agilent-048908) following the manufacturers instructions. After hybridization, microarrays were washed 1 minute at room temperature with GE Wash Buffer 1 (Agilent) and 1 minute with 37°C GE Wash buffer 2 (Agilent) according the manufacturers protocol.

scan_protocol: Slides were scanned immediately after washing using a high resolution DNA Microarray Scanner (G2505B, Agilent Technologies) with 3 µm resoltion and 20 bit image depth

data_processing: The scanned microarray images were processed with the Image Analysis/Feature Extraction software G2567AA v. A.11.5.1.1 (Agilent Technologies) using default settings and the GE1_1105_Oct12 extraction protocol.

source_name: Peripheral Blood, PaxGene

label_protocol: Total RNA was amplified and labeled with the low input Quick-Amp Labelling Kit (Agilent Technologies) with cyanine 3-CTP followed by precipitation, purification, and quantification.

extract_protocol: mRNA was reverse transcribed and amplified using an oligo-dT-T7 promoter primer

treatment_protocol: Microarray experiments were performed as single-color hybridization. Cyanine-3 (Cy3) labeled cRNA was prepared from 100 ng total RNA using the One-Color Low RNA Input Linear Amplification PLUS kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.

value: whole blood

tag: protocol

value: BOOSTRIX

tag: day

tag: participant

tag: gender

value: female

tag: age

tag: race

value: white

tag: ethnicity

value: not hispanic or latino

tag: recent boostrix


title: WholeBlood_CRC305D2GENT113613_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT113613 on day 0


title: WholeBlood_CRC305D2GENT210128_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT210128 on day 28

value: male


title: WholeBlood_CRC305D2GENT212321_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT212321 on day 28


title: WholeBlood_CRC305D2GENT141520_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT141520 on day 28


title: WholeBlood_CRC305D2GENT206311_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT206311 on day 1


title: WholeBlood_CRC305D2GENT033808_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT033808 on day 1


title: WholeBlood_CRC305D2GENT234325_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT234325 on day 28


title: WholeBlood_CRC305D2GENT117514_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT117514 on day 0


title: WholeBlood_CRC305D2GENT048104_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT048104 on day 7


title: WholeBlood_CRC305D2GENT096505_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT096505 on day 1


title: WholeBlood_CRC305D2GENT194123_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT194123 on day 28


title: WholeBlood_CRC305D2GENT053603_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT053603 on day 7


title: WholeBlood_CRC305D2GENT044706_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT044706 on day 1


title: WholeBlood_CRC305D2GENT159414_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT159414 on day 0


title: WholeBlood_CRC305D2GENT006302_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT006302 on day 7


title: WholeBlood_CRC305D2GENT031404_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT031404 on day 7


title: WholeBlood_CRC305D2GENT022102_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT022102 on day 0


title: WholeBlood_CRC305D2GENT065716_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT065716 on day 1


title: WholeBlood_CRC305D2GENT161312_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT161312 on day 0


title: WholeBlood_CRC305D2GENT215728_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT215728 on day 3


title: WholeBlood_CRC305D2GENT139420_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT139420 on day 0


title: WholeBlood_CRC305D2GENT044706_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT044706 on day 7


title: WholeBlood_CRC305D2GENT007803_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT007803 on day 1

value: black or african american


title: WholeBlood_CRC305D2GENT041206_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT041206 on day 7


title: WholeBlood_CRC305D2GENT246830_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT246830 on day 7


title: WholeBlood_CRC305D2GENT020501_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT020501 on day 1


title: WholeBlood_CRC305D2GENT031404_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT031404 on day 1


title: WholeBlood_CRC305D2GENT092606_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT092606 on day 1


title: WholeBlood_CRC305D2GENT173623_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT173623 on day 28


title: WholeBlood_CRC305D2GENT216625_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT216625 on day 1


title: WholeBlood_CRC305D2GENT225726_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT225726 on day 1


title: WholeBlood_CRC305D2GENT167815_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT167815 on day 28


title: WholeBlood_CRC305D2GENT121616_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT121616 on day 28


title: WholeBlood_CRC305D2GENT235222_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT235222 on day 7


title: WholeBlood_CRC305D2GENT174528_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT174528 on day 28


title: WholeBlood_CRC305D2GENT120415_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT120415 on day 28


title: WholeBlood_CRC305D2GENT173623_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT173623 on day 2


title: WholeBlood_CRC305D2GENT230324_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT230324 on day 3


title: WholeBlood_CRC305D2GENT246830_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT246830 on day 1


title: WholeBlood_CRC305D2GENT244825_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT244825 on day 28


title: WholeBlood_CRC305D2GENT237529_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT237529 on day 2


title: WholeBlood_CRC305D2GENT126819_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT126819 on day 1


title: WholeBlood_CRC305D2GENT067112_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT067112 on day 7


title: WholeBlood_CRC305D2GENT206311_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT206311 on day 7


title: WholeBlood_CRC305D2GENT169619_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT169619 on day 1


title: WholeBlood_CRC305D2GENT174528_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT174528 on day 7


title: WholeBlood_CRC305D2GENT223329_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT223329 on day 1


title: WholeBlood_CRC305D2GENT125418_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT125418 on day 7


title: WholeBlood_CRC305D2GENT060113_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT060113 on day 7


title: WholeBlood_CRC305D2GENT181523_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT181523 on day 2


title: WholeBlood_CRC305D2GENT138318_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT138318 on day 3


title: WholeBlood_CRC305D2GENT152421_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT152421 on day 28


title: WholeBlood_CRC305D2GENT204126_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT204126 on day 7


title: WholeBlood_CRC305D2GENT170426_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT170426 on day 7


title: WholeBlood_CRC305D2GENT188823_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT188823 on day 1


title: WholeBlood_CRC305D2GENT123818_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT123818 on day 1


title: WholeBlood_CRC305D2GENT148517_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT148517 on day 2


title: pat3_normal [RNA-seq]

city: Boston

first: JAE WON

last: CHO

state: MA

address: 60 Fenwood Road

department: Neurology

institute: Brigham and Women's Hospital

description: counts.txt

data_processing:
Read mapping: STAR-2.5.2a
Quantification: FeatureCounts
Genome_build: GRCH37.p13, release 19
Supplementary_files_format_and_content: tab-delimited text files include counts for each Sample ...

source_name: lung biopsies

extract_protocol:
Next-Gen Sequecing Sample Specification and Submission Guideline: RNA extraction protocol
TruSeq RNA Access Library Prep Guide Part # 15049525 Rev. B with TruSeq RNA Access Library Prep Kit

tag: tumor

value: normal


title: WholeBlood_CRC305D2GENT162816_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT162816 on day 1


title: WholeBlood_CRC305D2GENT167815_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT167815 on day 1


title: WholeBlood_CRC305D2GENT113613_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT113613 on day 1


title: WholeBlood_CRC305D2GENT117514_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT117514 on day 1


title: WholeBlood_CRC305D2GENT139420_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT139420 on day 1


title: WholeBlood_CRC305D2GENT158720_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT158720 on day 1


title: WholeBlood_CRC305D2GENT122614_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT122614 on day 1


title: WholeBlood_CRC305D2GENT164719_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT164719 on day 1


title: WholeBlood_CRC305D2GENT114615_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT114615 on day 1


title: WholeBlood_CRC305D2GENT090611_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT090611 on day 1


title: WholeBlood_CRC305D2GENT095612_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT095612 on day 1


title: WholeBlood_CRC305D2GENT163817_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT163817 on day 1


title: WholeBlood_CRC305D2GENT115515_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT115515 on day 1


title: WholeBlood_CRC305D2GENT125418_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT125418 on day 1


title: WholeBlood_CRC305D2GENT127417_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT127417 on day 1


title: WholeBlood_CRC305D2GENT166413_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT166413 on day 1


title: WholeBlood_CRC305D2GENT120415_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT120415 on day 1


title: WholeBlood_CRC305D2GENT157309_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT157309 on day 1


title: WholeBlood_CRC305D2GENT137419_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT137419 on day 1


title: WholeBlood_CRC305D2GENT175416_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT175416 on day 1


title: WholeBlood_CRC305D2GENT132315_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT132315 on day 1


title: WholeBlood_CRC305D2GENT159414_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT159414 on day 1


title: WholeBlood_CRC305D2GENT131313_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT131313 on day 1


title: WholeBlood_CRC305D2GENT104513_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT104513 on day 1


title: WholeBlood_CRC305D2GENT161312_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT161312 on day 1


title: WholeBlood_CRC305D2GENT129120_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT129120 on day 1


title: WholeBlood_CRC305D2GENT160412_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT160412 on day 1


title: WholeBlood_CRC305D2GENT165310_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT165310 on day 1


title: WholeBlood_CRC305D2GENT140314_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT140314 on day 1


title: WholeBlood_CRC305D2GENT116118_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT116118 on day 1


title: WholeBlood_CRC305D2GENT102216_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT102216 on day 1


title: WholeBlood_CRC305D2GENT126819_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT126819 on day 0


title: WholeBlood_CRC305D2GENT167815_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT167815 on day 0


title: WholeBlood_CRC305D2GENT162816_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT162816 on day 0


title: WholeBlood_CRC305D2GENT123818_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT123818 on day 0


title: WholeBlood_CRC305D2GENT118117_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT118117 on day 1


title: WholeBlood_CRC305D2GENT114615_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT114615 on day 0


title: WholeBlood_CRC305D2GENT065716_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT065716 on day 3


title: WholeBlood_CRC305D2GENT122614_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT122614 on day 0


title: WholeBlood_CRC305D2GENT087409_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT087409 on day 3


title: WholeBlood_CRC305D2GENT130119_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT130119 on day 0


title: WholeBlood_CRC305D2GENT158720_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT158720 on day 0


title: WholeBlood_CRC305D2GENT103114_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT103114 on day 2


title: WholeBlood_CRC305D2GENT106510_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT106510 on day 2


title: WholeBlood_CRC305D2GENT116118_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT116118 on day 0


title: WholeBlood_CRC305D2GENT083408_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT083408 on day 3


title: WholeBlood_CRC305D2GENT078509_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT078509 on day 2


title: WholeBlood_CRC305D2GENT095612_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT095612 on day 0


title: WholeBlood_CRC305D2GENT090611_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT090611 on day 0


title: WholeBlood_CRC305D2GENT163817_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT163817 on day 0


title: WholeBlood_CRC305D2GENT113613_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT113613 on day 2


title: WholeBlood_CRC305D2GENT060113_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT060113 on day 2


title: WholeBlood_CRC305D2GENT072715_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT072715 on day 3


title: WholeBlood_CRC305D2GENT118117_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT118117 on day 0


title: WholeBlood_CRC305D2GENT160412_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT160412 on day 0


title: WholeBlood_CRC305D2GENT122614_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT122614 on day 2


title: WholeBlood_CRC305D2GENT166413_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT166413 on day 0


title: WholeBlood_CRC305D2GENT130119_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT130119 on day 1


title: WholeBlood_CRC305D2GENT073508_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT073508 on day 2


title: WholeBlood_CRC305D2GENT161312_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT161312 on day 3


title: WholeBlood_CRC305D2GENT206311_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT206311 on day 3


title: WholeBlood_CRC305D2GENT115515_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT115515 on day 0


title: WholeBlood_CRC305D2GENT077110_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT077110 on day 2


title: WholeBlood_CRC305D2GENT067112_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT067112 on day 2


title: WholeBlood_CRC305D2GENT079714_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT079714 on day 3


title: WholeBlood_CRC305D2GENT095612_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT095612 on day 2


title: WholeBlood_CRC305D2GENT099713_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT099713 on day 3


title: WholeBlood_CRC305D2GENT105712_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT105712 on day 3


title: WholeBlood_CRC305D2GENT132315_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT132315 on day 0


title: WholeBlood_CRC305D2GENT075111_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT075111 on day 2


title: WholeBlood_CRC305D2GENT163817_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT163817 on day 3


title: WholeBlood_CRC305D2GENT090611_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT090611 on day 2


title: WholeBlood_CRC305D2GENT164719_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT164719 on day 0


title: WholeBlood_CRC305D2GENT089610_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT089610 on day 2


title: WholeBlood_CRC305D2GENT102216_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT102216 on day 2


title: WholeBlood_CRC305D2GENT140314_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT140314 on day 0


title: WholeBlood_CRC305D2GENT162816_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT162816 on day 3


title: WholeBlood_CRC305D2GENT131313_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT131313 on day 0


title: WholeBlood_CRC305D2GENT061711_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT061711 on day 3


title: WholeBlood_CRC305D2GENT157309_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT157309 on day 3


title: WholeBlood_CRC305D2GENT165310_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT165310 on day 3


title: WholeBlood_CRC305D2GENT112214_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT112214 on day 2


title: WholeBlood_CRC305D2GENT111215_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT111215 on day 2


title: WholeBlood_CRC305D2GENT088609_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT088609 on day 2


title: WholeBlood_CRC305D2GENT101710_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT101710 on day 3


title: WholeBlood_CRC305D2GENT069608_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT069608 on day 2


title: WholeBlood_CRC305D2GENT002805_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT002805 on day 7


title: WholeBlood_CRC305D2GENT119308_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT119308 on day 3


title: WholeBlood_CRC305D2GENT076814_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT076814 on day 3


title: WholeBlood_CRC305D2GENT104513_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT104513 on day 0


title: WholeBlood_CRC305D2GENT167815_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT167815 on day 3


title: WholeBlood_CRC305D2GENT070307_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT070307 on day 3


title: WholeBlood_CRC305D2GENT080109_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT080109 on day 2


title: WholeBlood_CRC305D2GENT206311_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT206311 on day 0


title: WholeBlood_CRC305D2GENT130119_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT130119 on day 2


title: WholeBlood_CRC305D2GENT137419_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT137419 on day 0


title: WholeBlood_CRC305D2GENT129120_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT129120 on day 2


title: WholeBlood_CRC305D2GENT108813_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT108813 on day 3


title: WholeBlood_CRC305D2GENT115515_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT115515 on day 2


title: WholeBlood_CRC305D2GENT159414_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT159414 on day 3


title: WholeBlood_CRC305D2GENT024804_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT024804 on day 7


title: WholeBlood_CRC305D2GENT127417_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT127417 on day 0


title: WholeBlood_CRC305D2GENT082306_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT082306 on day 3


title: WholeBlood_CRC305D2GENT158720_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT158720 on day 3


title: WholeBlood_CRC305D2GENT165310_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT165310 on day 0


title: WholeBlood_CRC305D2GENT116118_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT116118 on day 2


title: WholeBlood_CRC305D2GENT125418_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT125418 on day 0


title: WholeBlood_CRC305D2GENT128617_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT128617 on day 2


title: WholeBlood_CRC305D2GENT102216_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT102216 on day 0


title: WholeBlood_CRC305D2GENT164719_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT164719 on day 3


title: WholeBlood_CRC305D2GENT166413_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT166413 on day 3


title: WholeBlood_CRC305D2GENT117514_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT117514 on day 2


title: WholeBlood_CRC305D2GENT175416_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT175416 on day 0


title: WholeBlood_CRC305D2GENT118117_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT118117 on day 2


title: WholeBlood_CRC305D2GENT007803_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT007803 on day 7


title: WholeBlood_CRC305D2GENT157309_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT157309 on day 0


title: WholeBlood_CRC305D2GENT081411_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT081411 on day 3


title: WholeBlood_CRC305D2GENT160412_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT160412 on day 3


title: WholeBlood_CRC305D2GENT068718_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT068718 on day 3


title: WholeBlood_CRC305D2GENT121616_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT121616 on day 2


title: WholeBlood_CRC305D2GENT004801_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT004801 on day 7


title: WholeBlood_CRC305D2GENT038709_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT038709 on day 7


title: WholeBlood_CRC305D2GENT109116_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT109116 on day 2


title: WholeBlood_CRC305D2GENT120415_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT120415 on day 0


title: WholeBlood_CRC305D2GENT071717_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT071717 on day 3


title: WholeBlood_CRC305D2GENT104513_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT104513 on day 2


title: WholeBlood_CRC305D2GENT129120_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT129120 on day 0


title: WholeBlood_CRC305D2GENT110512_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT110512 on day 2


title: WholeBlood_CRC305D2GENT114615_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT114615 on day 2


title: WholeBlood_CRC305D2GENT101710_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT101710 on day 1


title: WholeBlood_CRC305D2GENT100115_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT100115 on day 2


title: WholeBlood_CRC305D2GENT083408_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT083408 on day 1


title: WholeBlood_CRC305D2GENT017702_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT017702 on day 7


title: WholeBlood_CRC305D2GENT077110_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT077110 on day 1


title: WholeBlood_CRC305D2GENT101710_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT101710 on day 0


title: WholeBlood_CRC305D2GENT056103_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT056103 on day 7


title: WholeBlood_CRC305D2GENT077110_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT077110 on day 0


title: WholeBlood_CRC305D2GENT080109_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT080109 on day 0


title: WholeBlood_CRC305D2GENT070307_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT070307 on day 1


title: WholeBlood_CRC305D2GENT119308_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT119308 on day 1


title: WholeBlood_CRC305D2GENT088609_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT088609 on day 0


title: WholeBlood_CRC305D2GENT076814_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT076814 on day 1


title: WholeBlood_CRC305D2GENT083408_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT083408 on day 0


title: WholeBlood_CRC305D2GENT037812_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT037812 on day 7


title: WholeBlood_CRC305D2GENT076814_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT076814 on day 0


title: WholeBlood_CRC305D2GENT089610_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT089610 on day 0


title: WholeBlood_CRC305D2GENT049503_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT049503 on day 7


title: WholeBlood_CRC305D2GENT108813_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT108813 on day 1


title: WholeBlood_CRC305D2GENT119308_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT119308 on day 0


title: WholeBlood_CRC305D2GENT082306_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT082306 on day 1


title: WholeBlood_CRC305D2GENT080109_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT080109 on day 1


title: WholeBlood_CRC305D2GENT035407_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT035407 on day 7


title: WholeBlood_CRC305D2GENT089610_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT089610 on day 1


title: WholeBlood_CRC305D2GENT108813_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT108813 on day 0


title: WholeBlood_CRC305D2GENT088609_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT088609 on day 1


title: WholeBlood_CRC305D2GENT069608_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT069608 on day 0


title: WholeBlood_CRC305D2GENT069608_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT069608 on day 1


title: WholeBlood_CRC305D2GENT009403_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT009403 on day 7


title: WholeBlood_CRC305D2GENT111215_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT111215 on day 1


title: WholeBlood_CRC305D2GENT040811_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT040811 on day 7


title: WholeBlood_CRC305D2GENT068718_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT068718 on day 1


title: WholeBlood_CRC305D2GENT068718_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT068718 on day 0


title: WholeBlood_CRC305D2GENT065716_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT065716 on day 0


title: WholeBlood_CRC305D2GENT109116_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT109116 on day 0


title: WholeBlood_CRC305D2GENT107511_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT107511 on day 2


title: WholeBlood_CRC305D2GENT016402_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT016402 on day 7


title: WholeBlood_CRC305D2GENT070307_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT070307 on day 0


title: WholeBlood_CRC305D2GENT082306_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT082306 on day 0


title: WholeBlood_CRC305D2GENT107511_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT107511 on day 1


title: WholeBlood_CRC305D2GENT106510_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT106510 on day 0


title: WholeBlood_CRC305D2GENT112214_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT112214 on day 1


title: WholeBlood_CRC305D2GENT071717_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT071717 on day 1


title: WholeBlood_CRC305D2GENT109116_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT109116 on day 1


title: WholeBlood_CRC305D2GENT110512_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT110512 on day 0


title: WholeBlood_CRC305D2GENT110512_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT110512 on day 1


title: WholeBlood_CRC305D2GENT019810_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT019810 on day 7


title: WholeBlood_CRC305D2GENT074410_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT074410 on day 3


title: WholeBlood_CRC305D2GENT106510_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT106510 on day 1


title: WholeBlood_CRC305D2GENT028809_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT028809 on day 7


title: WholeBlood_CRC305D2GENT033808_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT033808 on day 7


title: WholeBlood_CRC305D2GENT072715_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT072715 on day 1


title: WholeBlood_CRC305D2GENT015401_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT015401 on day 7


title: WholeBlood_CRC305D2GENT107511_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT107511 on day 0


title: WholeBlood_CRC305D2GENT100115_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT100115 on day 1


title: WholeBlood_CRC305D2GENT111215_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT111215 on day 0


title: WholeBlood_CRC305D2GENT112214_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT112214 on day 0


title: WholeBlood_CRC305D2GENT071717_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT071717 on day 0


title: WholeBlood_CRC305D2GENT001301_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT001301 on day 7


title: WholeBlood_CRC305D2GENT100115_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT100115 on day 0


title: WholeBlood_CRC305D2GENT078509_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT078509 on day 0


title: WholeBlood_CRC305D2GENT072715_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT072715 on day 0


title: WholeBlood_CRC305D2GENT079714_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT079714 on day 1


title: WholeBlood_CRC305D2GENT078509_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT078509 on day 1


title: WholeBlood_CRC305D2GENT103114_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT103114 on day 1


title: WholeBlood_CRC305D2GENT032807_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT032807 on day 7


title: WholeBlood_CRC305D2GENT086806_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT086806 on day 7


title: WholeBlood_CRC305D2GENT103114_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT103114 on day 0


title: WholeBlood_CRC305D2GENT073508_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT073508 on day 0


title: WholeBlood_CRC305D2GENT099713_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT099713 on day 1


title: WholeBlood_CRC305D2GENT081411_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT081411 on day 1


title: WholeBlood_CRC305D2GENT013802_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT013802 on day 7


title: WholeBlood_CRC305D2GENT081411_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT081411 on day 0


title: WholeBlood_CRC305D2GENT073508_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT073508 on day 1


title: WholeBlood_CRC305D2GENT060113_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT060113 on day 1


title: WholeBlood_CRC305D2GENT079714_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT079714 on day 0


title: WholeBlood_CRC305D2GENT099713_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT099713 on day 0


title: WholeBlood_CRC305D2GENT074410_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT074410 on day 1


title: WholeBlood_CRC305D2GENT067112_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT067112 on day 1


title: WholeBlood_CRC305D2GENT052210_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT052210 on day 7


title: WholeBlood_CRC305D2GENT057211_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT057211 on day 7


title: WholeBlood_CRC305D2GENT105712_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT105712 on day 1


title: WholeBlood_CRC305D2GENT060113_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT060113 on day 0


title: WholeBlood_CRC305D2GENT105712_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT105712 on day 0


title: WholeBlood_CRC305D2GENT054105_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT054105 on day 7


title: WholeBlood_CRC305D2GENT022102_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT022102 on day 7


title: WholeBlood_CRC305D2GENT074410_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT074410 on day 0


title: WholeBlood_CRC305D2GENT061711_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT061711 on day 1


title: WholeBlood_CRC305D2GENT043707_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT043707 on day 7


title: WholeBlood_CRC305D2GENT036705_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT036705 on day 7


title: WholeBlood_CRC305D2GENT039708_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT039708 on day 7


title: WholeBlood_CRC305D2GENT136101_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT136101 on day 7


title: WholeBlood_CRC305D2GENT020501_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT020501 on day 2


title: WholeBlood_CRC305D2GENT027405_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT027405 on day 3


title: WholeBlood_CRC305D2GENT087409_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT087409 on day 0


title: WholeBlood_CRC305D2GENT013802_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT013802 on day 3


title: WholeBlood_CRC305D2GENT026202_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT026202 on day 2


title: WholeBlood_CRC305D2GENT098213_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT098213 on day 2


title: WholeBlood_CRC305D2GENT029704_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT029704 on day 7


title: WholeBlood_CRC305D2GENT050208_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT050208 on day 7


title: WholeBlood_CRC305D2GENT004801_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT004801 on day 3


title: WholeBlood_CRC305D2GENT067112_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT067112 on day 0


title: WholeBlood_CRC305D2GENT014201_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT014201 on day 2


title: WholeBlood_CRC305D2GENT023304_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT023304 on day 7


title: WholeBlood_CRC305D2GENT061711_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT061711 on day 0


title: WholeBlood_CRC305D2GENT045406_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT045406 on day 3


title: WholeBlood_CRC305D2GENT051604_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT051604 on day 2


title: WholeBlood_CRC305D2GENT034305_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT034305 on day 7


title: WholeBlood_CRC305D2GENT037812_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT037812 on day 3


title: WholeBlood_CRC305D2GENT087409_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT087409 on day 1


title: WholeBlood_CRC305D2GENT075111_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT075111 on day 1


title: WholeBlood_CRC305D2GENT085108_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT085108 on day 2


title: WholeBlood_CRC305D2GENT038709_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT038709 on day 3


title: WholeBlood_CRC305D2GENT009403_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT009403 on day 3


title: WholeBlood_CRC305D2GENT091212_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT091212 on day 2


title: WholeBlood_CRC305D2GENT031404_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT031404 on day 3


title: WholeBlood_CRC305D2GENT030703_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT030703 on day 7


title: WholeBlood_CRC305D2GENT025303_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT025303 on day 7


title: WholeBlood_CRC305D2GENT075111_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT075111 on day 0


title: WholeBlood_CRC305D2GENT039708_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT039708 on day 3


title: WholeBlood_CRC305D2GENT057211_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT057211 on day 2


title: WholeBlood_CRC305D2GENT058107_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT058107 on day 2


title: WholeBlood_CRC305D2GENT053603_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT053603 on day 2


title: WholeBlood_CRC305D2GENT040811_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT040811 on day 3


title: WholeBlood_CRC305D2GENT016402_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT016402 on day 3


title: WholeBlood_CRC305D2GENT094605_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT094605 on day 2


title: WholeBlood_CRC305D2GENT044706_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT044706 on day 3


title: WholeBlood_CRC305D2GENT003701_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT003701 on day 7


title: WholeBlood_CRC305D2GENT055209_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT055209 on day 7


title: WholeBlood_CRC305D2GENT052210_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT052210 on day 2


title: WholeBlood_CRC305D2GENT021601_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT021601 on day 2


title: WholeBlood_CRC305D2GENT043707_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT043707 on day 3


title: WholeBlood_CRC305D2GENT033808_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT033808 on day 3


title: WholeBlood_CRC305D2GENT015401_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT015401 on day 3


title: WholeBlood_CRC305D2GENT054105_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT054105 on day 2


title: WholeBlood_CRC305D2GENT010602_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT010602 on day 2


title: WholeBlood_CRC305D2GENT093106_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT093106 on day 2


title: WholeBlood_CRC305D2GENT028809_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT028809 on day 3


title: WholeBlood_CRC305D2GENT019810_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT019810 on day 3


title: WholeBlood_CRC305D2GENT092606_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT092606 on day 2


title: WholeBlood_CRC305D2GENT051604_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT051604 on day 7


title: WholeBlood_CRC305D2GENT055209_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT055209 on day 2


title: WholeBlood_CRC305D2GENT047207_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT047207 on day 7


title: WholeBlood_CRC305D2GENT059507_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT059507 on day 2


title: WholeBlood_CRC305D2GENT036705_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT036705 on day 3


title: WholeBlood_CRC305D2GENT066205_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT066205 on day 7


title: WholeBlood_CRC305D2GENT048104_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT048104 on day 2


title: WholeBlood_CRC305D2GENT021601_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT021601 on day 7


title: WholeBlood_CRC305D2GENT050208_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT050208 on day 2


title: WholeBlood_CRC305D2GENT023304_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT023304 on day 3


title: WholeBlood_CRC305D2GENT034305_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT034305 on day 3


title: WholeBlood_CRC305D2GENT032807_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT032807 on day 3


title: WholeBlood_CRC305D2GENT056103_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT056103 on day 2


title: WholeBlood_CRC305D2GENT086806_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT086806 on day 3


title: WholeBlood_CRC305D2GENT046502_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT046502 on day 7


title: WholeBlood_CRC305D2GENT097506_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT097506 on day 2


title: WholeBlood_CRC305D2GENT030703_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT030703 on day 3


title: WholeBlood_CRC305D2GENT096505_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT096505 on day 2


title: WholeBlood_CRC305D2GENT041206_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT041206 on day 2


title: WholeBlood_CRC305D2GENT017702_Day3

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT017702 on day 3


title: WholeBlood_CRC305D2GENT042203_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT042203 on day 7


title: WholeBlood_CRC305D2GENT022102_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT022102 on day 2


title: WholeBlood_CRC305D2GENT064504_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT064504 on day 2


title: WholeBlood_CRC305D2GENT134204_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT134204 on day 7


title: WholeBlood_CRC305D2GENT002805_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT002805 on day 3


title: WholeBlood_CRC305D2GENT025303_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT025303 on day 3


title: WholeBlood_CRC305D2GENT003701_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT003701 on day 3


title: WholeBlood_CRC305D2GENT049503_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT049503 on day 2


title: WholeBlood_CRC305D2GENT019810_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT019810 on day 1


title: WholeBlood_CRC305D2GENT136101_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT136101 on day 2


title: WholeBlood_CRC305D2GENT066205_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT066205 on day 2


title: WholeBlood_CRC305D2GENT134204_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT134204 on day 2


title: WholeBlood_CRC305D2GENT024804_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT024804 on day 3


title: WholeBlood_CRC305D2GENT020501_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT020501 on day 7


title: WholeBlood_CRC305D2GENT014201_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT014201 on day 7


title: WholeBlood_CRC305D2GENT045406_Day7

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT045406 on day 7


title: WholeBlood_CRC305D2GENT006302_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT006302 on day 3


title: WholeBlood_CRC305D2GENT026202_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT026202 on day 7


title: WholeBlood_CRC305D2GENT007803_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT007803 on day 3


title: WholeBlood_CRC305D2GENT046502_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT046502 on day 2


title: WholeBlood_CRC305D2GENT042203_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT042203 on day 2


title: WholeBlood_CRC305D2GENT027405_Day7

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT027405 on day 7


title: WholeBlood_CRC305D2GENT063607_Day2

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT063607 on day 2


title: WholeBlood_CRC305D2GENT047207_Day2

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT047207 on day 2


title: WholeBlood_CRC305D2GENT028809_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT028809 on day 1


title: WholeBlood_CRC305D2GENT029704_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT029704 on day 3


title: WholeBlood_CRC305D2GENT035407_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT035407 on day 3


title: WholeBlood_CRC305D2GENT097506_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT097506 on day 0


title: WholeBlood_CRC305D2GENT047207_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT047207 on day 1


title: WholeBlood_CRC305D2GENT058107_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT058107 on day 0


title: WholeBlood_CRC305D2GENT064504_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT064504 on day 1


title: WholeBlood_CRC305D2GENT001301_Day3

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT001301 on day 3


title: WholeBlood_CRC305D2GENT055209_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT055209 on day 0


title: WholeBlood_CRC305D2GENT021601_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT021601 on day 0


title: WholeBlood_CRC305D2GENT032807_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT032807 on day 1


title: WholeBlood_CRC305D2GENT002805_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT002805 on day 0


title: WholeBlood_CRC305D2GENT086806_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT086806 on day 0


title: WholeBlood_CRC305D2GENT093106_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT093106 on day 0


title: WholeBlood_CRC305D2GENT038709_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT038709 on day 0


title: WholeBlood_CRC305D2GENT047207_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT047207 on day 0


title: WholeBlood_CRC305D2GENT050208_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT050208 on day 0


title: WholeBlood_CRC305D2GENT085108_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT085108 on day 1


title: WholeBlood_CRC305D2GENT039708_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT039708 on day 0


title: WholeBlood_CRC305D2GENT096505_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT096505 on day 0


title: WholeBlood_CRC305D2GENT093106_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT093106 on day 1


title: WholeBlood_CRC305D2GENT029704_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT029704 on day 1


title: WholeBlood_CRC305D2GENT049503_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT049503 on day 0


title: WholeBlood_CRC305D2GENT058107_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT058107 on day 1


title: WholeBlood_CRC305D2GENT046502_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT046502 on day 1


title: WholeBlood_CRC305D2GENT086806_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT086806 on day 1


title: WholeBlood_CRC305D2GENT049503_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT049503 on day 1


title: WholeBlood_CRC305D2GENT046502_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT046502 on day 0


title: WholeBlood_CRC305D2GENT064504_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT064504 on day 0


title: WholeBlood_CRC305D2GENT035407_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT035407 on day 0


title: WholeBlood_CRC305D2GENT030703_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT030703 on day 1


title: WholeBlood_CRC305D2GENT043707_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT043707 on day 0


title: WholeBlood_CRC305D2GENT041206_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT041206 on day 0


title: WholeBlood_CRC305D2GENT024804_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT024804 on day 0


title: WholeBlood_CRC305D2GENT045406_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT045406 on day 1


title: WholeBlood_CRC305D2GENT044706_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT044706 on day 0


title: WholeBlood_CRC305D2GENT030703_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT030703 on day 0


title: WholeBlood_CRC305D2GENT017702_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT017702 on day 0


title: WholeBlood_CRC305D2GENT029704_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT029704 on day 0


title: WholeBlood_CRC305D2GENT020501_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT020501 on day 0


title: WholeBlood_CRC305D2GENT045406_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT045406 on day 0


title: WholeBlood_CRC305D2GENT048104_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT048104 on day 1


title: WholeBlood_CRC305D2GENT027405_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT027405 on day 1


title: WholeBlood_CRC305D2GENT034305_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT034305 on day 0


title: WholeBlood_CRC305D2GENT040811_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT040811 on day 0


title: WholeBlood_CRC305D2GENT036705_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT036705 on day 0


title: WholeBlood_CRC305D2GENT066205_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT066205 on day 0


title: WholeBlood_CRC305D2GENT027405_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT027405 on day 0


title: WholeBlood_CRC305D2GENT063607_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT063607 on day 1


title: WholeBlood_CRC305D2GENT007803_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT007803 on day 0


title: WholeBlood_CRC305D2GENT013802_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT013802 on day 0


title: WholeBlood_CRC305D2GENT056103_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT056103 on day 1


title: WholeBlood_CRC305D2GENT016402_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT016402 on day 0


title: WholeBlood_CRC305D2GENT009403_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT009403 on day 0


title: WholeBlood_CRC305D2GENT094605_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT094605 on day 1


title: WholeBlood_CRC305D2GENT134204_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT134204 on day 0


title: WholeBlood_CRC305D2GENT037812_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT037812 on day 0


title: WholeBlood_CRC305D2GENT031404_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT031404 on day 0


title: WholeBlood_CRC305D2GENT023304_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT023304 on day 0


title: WholeBlood_CRC305D2GENT026202_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT026202 on day 0


title: WholeBlood_CRC305D2GENT034305_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT034305 on day 1


title: WholeBlood_CRC305D2GENT004801_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT004801 on day 0


title: WholeBlood_CRC305D2GENT053603_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT053603 on day 1


title: WholeBlood_CRC305D2GENT006302_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT006302 on day 0


title: WholeBlood_CRC305D2GENT025303_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT025303 on day 0


title: WholeBlood_CRC305D2GENT019810_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT019810 on day 0


title: WholeBlood_CRC305D2GENT023304_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT023304 on day 1


title: WholeBlood_CRC305D2GENT051604_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT051604 on day 1


title: WholeBlood_CRC305D2GENT042203_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT042203 on day 0


title: WholeBlood_CRC305D2GENT059507_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT059507 on day 1


title: WholeBlood_CRC305D2GENT063607_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT063607 on day 0


title: WholeBlood_CRC305D2GENT025303_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT025303 on day 1


title: WholeBlood_CRC305D2GENT014201_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT014201 on day 0


title: WholeBlood_CRC305D2GENT092606_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT092606 on day 0


title: WholeBlood_CRC305D2GENT001301_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT001301 on day 0


title: WholeBlood_CRC305D2GENT098213_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT098213 on day 0


title: WholeBlood_CRC305D2GENT098213_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT098213 on day 1


title: WholeBlood_CRC305D2GENT091212_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT091212 on day 0


title: WholeBlood_CRC305D2GENT033808_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT033808 on day 0


title: WholeBlood_CRC305D2GENT028809_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT028809 on day 0


title: WholeBlood_CRC305D2GENT003701_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT003701 on day 0


title: WholeBlood_CRC305D2GENT051604_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT051604 on day 0


title: WholeBlood_CRC305D2GENT057211_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT057211 on day 0


title: WholeBlood_CRC305D2GENT097506_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT097506 on day 1


title: WholeBlood_CRC305D2GENT054105_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT054105 on day 0


title: WholeBlood_CRC305D2GENT053603_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT053603 on day 0


title: WholeBlood_CRC305D2GENT094605_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT094605 on day 0


title: WholeBlood_CRC305D2GENT048104_Day0

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT048104 on day 0


title: RE5_sequence

city: jinan

first: Qi

middle: shuai

last: Zhuang

address: Shandong First Medical University, Qingdao Road, Huaiyin District

country: China

institute: Shandong First Medical University

data_processing:
Basecalls performed using CASAVA version 1.8
Genome_build: hg38
Supplementary_files_format_and_content: counts

source_name: amygdala

extract_protocol:
RNA high throughput sequencing was performed by Cloud-Seq Biotech (Shanghai, China). Briefly, total RNA was used for removing the rRNAs with NEBNext rRNA Depletion Kit (New England Biolabs, Inc., Massachusetts, USA) following the manufacturer's instructions. RNA libraries were constructed by using NEBNext Ultra II Directional RNA Library Prep Kit (New England Biolabs, Inc., Massachusetts, USA) according to the manufacturer’s instructions. Libraries were controlled for quality and quantified using the BioAnalyzer 2100 system (Agilent Technologies, Inc., USA). Library sequencing was performed on an illumina Hiseq instrument with 150bp paired end reads
Total RNA of each sample was used to prepare the miRNA sequencing library, which included the following steps: 1) 3'-adaptor ligation; 2) 5'-adaptor ligation; 3) cDNA synthesis; 4) PCR amplification; 5) Size selection of ~150 bp PCR amplicons (corresponding to ~22nt miRNAs) The libraries were denatured as single-stranded DNA molecules, captured on Illumina flow cells, amplified in situ as clusters and finally sequenced for 50 cycles on Illumina HiSeq sequencer following the manufacturer's instructions.

tag: tag

value: fear memory retrieval-extinction group (RE)

value: amygdala

value: 10 weeks


title: WholeBlood_CRC305D2GENT059507_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT059507 on day 0


title: WholeBlood_CRC305D2GENT032807_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT032807 on day 0


title: RE4_sequence


title: WholeBlood_CRC305D2GENT091212_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT091212 on day 1


title: WholeBlood_CRC305D2GENT085108_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT085108 on day 0


title: RE3_sequence


title: F2_sequence

value: memory formation (F)


title: F3_sequence


title: F1_sequence


title: E3_sequence

value: fear memory extinction group (E)


title: WholeBlood_CRC305D2GENT010602_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT010602 on day 0


title: WholeBlood_CRC305D2GENT052210_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT052210 on day 0


title: WholeBlood_CRC305D2GENT056103_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT056103 on day 0


title: WholeBlood_CRC305D2GENT022102_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT022102 on day 1


title: WholeBlood_CRC305D2GENT022102_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT022102 on day 28


title: WholeBlood_CRC305D2GENT030703_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT030703 on day 28


title: WholeBlood_CRC305D2GENT136101_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT136101 on day 0


title: WholeBlood_CRC305D2GENT057211_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT057211 on day 1


title: WholeBlood_CRC305D2GENT017702_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT017702 on day 28


title: WholeBlood_CRC305D2GENT036705_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT036705 on day 1


title: E2_sequence


title: WholeBlood_CRC305D2GENT001301_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT001301 on day 1


title: RE5

data_processing:
Basecalls performed using CASAVA version 1.8
circRNA-seq reads were mapped to human genome by BWA-MEM software by default parameters except -T = 19
circRNAs were detected and annotated with CIRI software
Genome_build: hg19
Supplementary_files_format_and_content: Number of raw junction read
Supplementary_files_format_and_content: FPKM

tag: group

value: retrieval-extinction training (RE)


title: WholeBlood_CRC305D2GENT193628_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT193628 on day 28

tag: treatment


title: CON2_sequence

value: control


title: E1_sequence


title: WholeBlood_CRC305D2GENT136101_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT136101 on day 1


title: CON1_sequence


title: CON3_sequence


title: RE4


title: WholeBlood_CRC305D2GENT023304_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT023304 on day 28


title: WholeBlood_CRC305D2GENT025303_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT025303 on day 28


title: F3

value: fear conditioning (F) training


title: RE3


title: F2


title: WholeBlood_CRC305D2GENT207627_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT207627 on day 28


title: WholeBlood_CRC305D2GENT136101_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT136101 on day 28


title: WholeBlood_CRC305D2GENT037812_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT037812 on day 1


title: F1


title: E3

value: fear extinction training (E)


title: WholeBlood_CRC305D2GENT052210_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT052210 on day 1

value: whole blood


title: E2


title: WholeBlood_CRC305D2GENT019810_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT019810 on day 28

value: BOOSTRIX


title: WholeBlood_CRC305D2GENT006302_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT006302 on day 28


title: WholeBlood_CRC305D2GENT015401_Day0

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT015401 on day 0


title: CON3

value: Control


title: Cd11b+Mac Mettl3-LysM-KO rep2

city: New Haven

first: Xinshou

last: Ouyang

state: CT

address: 1 Gilbert street

department: Internal Medicine

institute: Yale University

data_processing:
Alignment using STAR 2.6 against mouse reference genome mm10 normzlized using total counts methods.
the mouse genome (mm10, GRCm38) using Partek Flow software.
Genome_build: mm10
Supplementary_files_format_and_content: normalized totalcounts.txt

source_name: CD11b+F4/80+ cells from Spleen

extract_protocol:
The total RNA was extracted from CD11b+F4/80+ spleen macrophages using miRNeasy mini kit  (GIAGEN).
1 μg of total RNA was subjected to library synthesis using the TruSeq V2 RNA-Seq kit.  1 μg of total RNA was enriched for the Poly-A mRNA and reverse transcribed to double-stranded cDNA. Sequencing was performed using 12pM hybridization to a 2x100 paired end flow cell.

treatment_protocol: The C57BL/6 mice were onnormal chow for 10 weeks. The total RNA was extracted from CD11b+F4/80+ cells isolated frm spleen.

tag: cell type

value: CD11b+F4/80 cells

value: Spleen

tag: genotype/variation


title: CON2


title: E1


title: WholeBlood_CRC305D2GENT003701_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT003701 on day 28

value: female

value: white

value: not hispanic or latino


title: WholeBlood_CRC305D2GENT184626_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT184626 on day 28


title: Cd11b+Mac Mettl3-LysM-KO rep1

tag: strain


title: WholeBlood_CRC305D2GENT003701_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT003701 on day 1

tag: tissue


title: WholeBlood_CRC305D2GENT246830_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT246830 on day 28


title: WholeBlood_CRC305D2GENT017702_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT017702 on day 1


title: WholeBlood_CRC305D2GENT055209_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT055209 on day 1

value: male


title: WholeBlood_CRC305D2GENT040811_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT040811 on day 1


title: WholeBlood_CRC305D2GENT051604_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT051604 on day 28


title: WholeBlood_CRC305D2GENT242829_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT242829 on day 28


title: WholeBlood_CRC305D2GENT001301_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT001301 on day 28


title: WholeBlood_CRC305D2GENT028809_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT028809 on day 28


title: CD11b+Mac WT rep1

value: wild type


title: CON1

value: amygdala

value: 10 weeks


title: V6_5_mESCs_IP1

city: La Jolla

first: Gene

last: Yeo

state: CA

address: 2880 Torrey Pines Scenic Dr. Room 3805/Yeo Lab

institute: UCSD

data_processing:
Raw sequencing reads were trimmed for adapter sequences and barcode sequences (eCLIP samples) using cutadapt. Trimmed reads were mapped against RepBase to remove reads mapping to repetitive sequences. Remaining reads were mapped to the appropriate genome build using STAR aligner
RPKM values were calculated for all polysome samples. For eCLIP samples, read densities were calculated to identify eCLIP peaks.
eclip data processing pipeline can be requested from the following link : https://github.com/YeoLab/eclip
Genome_build: mm10 and hg19
Supplementary_files_format_and_content: RPKM files for all polysome samples. eCLIP input normalized peaks in BED format. eCLIP reproduclible peaks in BED format. eCLIP normalized read densitied in BIGWIG format.

source_name: V6.5 mESCs

growth_protocol: for HEK293, standard cell culture in 10% FBS in DMEM; for mouse ESCs, cells were transitioned to feeder free conditions over 2 passage cycles and continuously maintained in 15%FBS, NEAA, NaPyr, 1000U/mL LIF in DMEM

extract_protocol:
Total and polysome derived RNA were extracted using Trizol reagent
Illumina polyA Total RNA kit

treatment_protocol: LIN28B transgenes, Sponge Construct and Controls were induced using 10ng/ml Doxycycline. Samples assayed 24-36 hours after induction.

value: V6.5 mESCs


title: V6_5_mESCs_IN1


title: V6_5_mESCs_IP5


title: WholeBlood_CRC305D2GENT221430_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT221430 on day 28


title: HPK_mESCs_IP7


title: HPK_mESCs_IP3


title: WholeBlood_CRC305D2GENT002805_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT002805 on day 1


title: WholeBlood_CRC305D2GENT010602_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT010602 on day 1


title: V6_5_mock_2_poly


title: V6_5_mock_1_poly


title: HPK_mESCs_IN3


title: V6_5_mock_2


title: WholeBlood_CRC305D2GENT050208_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT050208 on day 1


title: WholeBlood_CRC305D2GENT033808_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT033808 on day 28


title: WholeBlood_CRC305D2GENT247730_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT247730 on day 28


title: WholeBlood_CRC305D2GENT041206_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT041206 on day 28


title: V6_5_mock_1


title: Hpk_mock_2_poly


title: Hpk_mock_2


title: WholeBlood_CRC305D2GENT220429_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT220429 on day 28


title: Hpk_mock_1


title: Hpk_mock_1_poly


title: dd-HpK-T-2

source_name: mESCs derived from Dicer(flox/flox) C57/BL6 mice


title: dd-HpK-T-1

value: mESCs derived from Dicer(flox/flox) C57/BL6 mice


title: CD11b+Mac WT rep2


title: dd-HpK-P-2


title: dd-HpK-P-1


title: WholeBlood_CRC305D2GENT021601_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT021601 on day 1


title: dd-Cit-T-1


title: dd-Cit-P-2


title: dd-Cit-P-1


title: B16-Tbx2-3xHA_cl09_siTbx2_R2

city: Oxford

first: Sizhu

last: Lu

address: Old Road Campus Research Building (off Roosevelt Drive)

department: Nuffield Department of Clinical Medicine

institute: Ludwig Institute for Cancer Research, Oxford branch

data_processing:
raw fastq files were examined for quality using Fastqc (version 0.11.7) and mapped against mm10 genome using STAR (version 2.6.1d)
Reads per gene from STAR output BAM file were counted using FeatureCounts (subread/1.6.2)
Counts per gene and sample information were converted to DeSeqDataSet objects and sequentially used as input for differential gene expression analysing using the R package Deseq2 (version 1.28.1)
Gene set enrichment analysis (GSEA) was carried out using the R package fgsea. 1,000 permutations were conducted for each gene set
Genome_build: mm10
Supplementary_files_format_and_content: excel table of DEGs

source_name: melanoma cells

extract_protocol:
cells were lysed to collect RNA using RNeasy mini kit (QIAGEN, 74106) according to the manufacturer’s protocol
ERCC ExFold RNA Spike-In Mixes (Ambion) was added prior to Library prep using QuantSeq 3’ mRNA-Seq Library Prep Kit, using 500 ng starting material to minimize the PCR amplfication step.

tag: cell line

value: B16-Tbx2-3xHA cl#09

value: transfected with siTbx2 for 48 h


title: B16-Tbx2-3xHA_cl09_siTbx2_R3


title: B16-Tbx2-3xHA_cl09_siTbx2_R1


title: dd-Cit-T-2


title: B16-Tbx2-3xHA_cl09_siCTR_R3

value: transfected with siCtrl for 48 h


title: B16-Tbx2-3xHA_cl09_siCTR_R2


title: B16-Tbx2-3xHA_cl09_NT_CTRL_R3


title: B16-Tbx2-3xHA_cl09_NT_CTRL_R2


title: WholeBlood_CRC305D2GENT024804_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT024804 on day 1

value: whole blood

tag: protocol


title: WholeBlood_CRC305D2GENT010602_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT010602 on day 28

value: BOOSTRIX

tag: day


title: WholeBlood_CRC305D2GENT041206_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT041206 on day 1

tag: participant


title: WholeBlood_CRC305D2GENT217330_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT217330 on day 28

tag: gender


title: WholeBlood_CRC305D2GENT086806_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT086806 on day 28

tag: age


title: B16-Tbx2-3xHA_cl09_NT_CTRL_R1


title: WholeBlood_CRC305D2GENT035407_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT035407 on day 1

tag: race


title: WholeBlood_CRC305D2GENT066205_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT066205 on day 1

tag: ethnicity


title: WholeBlood_CRC305D2GENT021601_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT021601 on day 28

tag: recent boostrix


title: B16-Tbx2-3xHA_cl09_siCTR_R1


title: WholeBlood_CRC305D2GENT178729_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT178729 on day 28


title: WholeBlood_CRC305D2GENT066205_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT066205 on day 28


title: WholeBlood_CRC305D2GENT032807_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT032807 on day 28


title: WholeBlood_CRC305D2GENT218428_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT218428 on day 28


title: B16-Tbx2-3xHA_cl02_siTbx2_R3

value: B16-Tbx2-3xHA cl#02


title: WholeBlood_CRC305D2GENT002805_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT002805 on day 28


title: B16-Tbx2-3xHA_cl02_siTbx2_R2


title: B16-Tbx2-3xHA_cl02_siTbx2_R1


title: WholeBlood_CRC305D2GENT134204_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT134204 on day 28


title: WholeBlood_CRC305D2GENT042203_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT042203 on day 28


title: WholeBlood_CRC305D2GENT223329_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT223329 on day 28


title: WholeBlood_CRC305D2GENT009403_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT009403 on day 1


title: WholeBlood_CRC305D2GENT020501_Day28

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT020501 on day 28


title: WholeBlood_CRC305D2GENT004801_Day1

description: Whole blood gene expression of PLACEBOD2 treated participant CRC305D2GENT004801 on day 1


title: B16-Tbx2-3xHA_cl02_siCTR_R2


title: B16-Tbx2-3xHA_cl02_siCTR_R3


title: WholeBlood_CRC305D2GENT134204_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT134204 on day 1


title: WholeBlood_CRC305D2GENT215728_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT215728 on day 28


title: WholeBlood_CRC305D2GENT013802_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT013802 on day 1


title: WholeBlood_CRC305D2GENT027405_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT027405 on day 28


title: WholeBlood_CRC305D2GENT024804_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT024804 on day 28


title: WholeBlood_CRC305D2GENT227727_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT227727 on day 28


title: B16-Tbx2-3xHA_cl02_siCTR_R1


title: WholeBlood_CRC305D2GENT042203_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT042203 on day 1


title: B16-Tbx2-3xHA_cl02_NT_CTRL_R3


title: B16-Tbx2-3xHA_cl02_NT_CTRL_R1


title: B16-Tbx2-3xHA_cl02_NT_CTRL_R2


title: B16-siTbx2_R1

value: B16 parental cells


title: WholeBlood_CRC305D2GENT026202_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT026202 on day 28


title: B16-siTbx2_R2


title: WholeBlood_CRC305D2GENT222328_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT222328 on day 28


title: WholeBlood_CRC305D2GENT038709_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT038709 on day 1


title: WholeBlood_CRC305D2GENT225726_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT225726 on day 28


title: WholeBlood_CRC305D2GENT031404_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT031404 on day 28


title: B16-siCTR_R3


title: WholeBlood_CRC305D2GENT016402_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT016402 on day 1


title: B16-siCTR_R2


title: B16-siCTR_R1


title: B16-NT_CTRL_R3


title: B16-NT_CTRL_R2


title: WholeBlood_CRC305D2GENT026202_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT026202 on day 1


title: B16-siTbx2_R3


title: T_CT26_Iso_mIgG1_2dose_8d_4

first: Eric

last: Muise

address: 33 Ave. Louis Pasteur

department: GPGX

institute: Merck

data_processing:
Cleaned reads were aligned to the Mouse.B38 genome reference using the Omicsoft Aligner (Qiagen, Germantown, MD) with a maximum of 2 allowed mismatches.
Gene level raw counts, and FPKM, were determined by the OSA algorithm as implemented in Omicsoft Array Studio (version 10.0.1.118) and using Ensembl.R93 gene models.
Genome_build: Mouse.B38
Supplementary_files_format_and_content: Tab-delimited text file include FPKM values for each Sample. Each column corresponds to one sample (barcode).

source_name: Tumor

growth_protocol: Each mouse was anesthetized and inoculated subcutaneously into the right lower flank with a single-cell suspension of ≥95% viable cells in 0.1 mL of serum-free DMEM or RPMI-1640 medium. Mice were checked daily for signs of notable clinical observations.

extract_protocol:
For tumor tissue RNA isolation, organs were homogenized into RNA STAT-60 (Tel-Test Inc., Friendswood, TX) using a polytron homogenizer, then total RNA extracted according to the manufacturer's instructions. After isopropanol precipitation, total RNA was re-extracted with phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma-Aldrich, St. Louis, MO) using phase-lock light tubes (Thermo Fisher Scientific, Foster City, CA).
RNA sequencing was performed using the Truseq stranded total RNA RiboZero library preparation kit (Catalog #: RS-122-2201) according to the manufacturer’s instructions (Illumina, San Diego, CA). The resulting cDNA libraries were sequenced on Illumina HiSeqTM 4000 using a 50 base paired-end run.

treatment_protocol: Tumor-bearing mice received muDX400, or muIgG1 isotype control, antibody injection at day 11 and day 15 post-tumor implant. Subsequently, on day 19 (“8d”) tumors were excised and snap frozen in liquid nitrogen and stored at –80°C until RNA isolation.

tag: replicate group

value: isotype control mIgG1

value: Partial

tag: time point


title: T_CT26_PD1_DX400_2dose_8d_1


title: T_4T1_PD1_DX400_2dose_8d_2

value: Resistant


title: B16-NT_CTRL_R1


title: WholeBlood_CRC305D2GENT014201_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT014201 on day 28

value: white

value: not hispanic or latino


title: WholeBlood_CRC305D2GENT007803_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT007803 on day 28

value: female

value: black or african american


title: T_4T1_Iso_mIgG1_2dose_8d_4


title: WholeBlood_CRC305D2GENT009403_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT009403 on day 28

value: male


title: WholeBlood_CRC305D2GENT228725_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT228725 on day 28


title: T_CT26_Iso_mIgG1_2dose_8d_3


title: T_CT26_Iso_mIgG1_2dose_8d_5


title: WholeBlood_CRC305D2GENT014201_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT014201 on day 1


title: WholeBlood_CRC305D2GENT039708_Day1

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT039708 on day 1


title: WholeBlood_CRC305D2GENT224327_Day28

description: Whole blood gene expression of BOOSTRIX treated participant CRC305D2GENT224327 on day 28